Webinar: How a Sponsored CMC Platform Accelerates mRNA Projects to the Clinic
On the pathway to GMP manufacturing in support of clinical trials, multiple technology transfers may correlate to an increase in complexity and risk...
Rapid response to emerging diseases is critical when developing a vaccine. Long RNA (mRNA and saRNA) is at the forefront of vaccine development.
Interested in a sample of saRNA? Use the link below to submit your request. If you have any other questions, please reach out to our client relations team for assisstance.
Request Sample
Increase the duration and level of antigen expression for a better immune response using self-amplifying RNA technology. Aldevron offers a synthetic replicon design based on a single-stranded RNA alphavirus that expresses GFP / SEAP / LUC reporter enzyme. For research use only, easily measure the reporter gene expression in vivo to evaluate self-amplifying RNA and optimize delivery formulations in your application.
Note: saRNA products are classified by Aldevron under ECCN 1C353 on the Commerce Control List set forth in the US Export Administration Regulations (EAR), which is highly controlled for purposes of export outside the United States. If the product is requested to be shipped outside the US, an export license from US Dept. of Commerce’s Bureau of Industry and Security is required before the product may be shipped.
Pack Sizes |
|||
AldGFP saRNA™
|
200µg
|
1mg
|
|
AldSEAP saRNA™
|
200µg
|
1mg
|
|
AldnLUC saRNA™
|
200µg
|
1mg
|
Appearance | Clear and colorless |
Buffer | Water |
Concentration | 1.0 mg/mL +/- 10% |
Purity Based on 260/280 Absorbance Ratio (mRNA) | Report Results |
Endotoxin | ≤ 100 EU/mg |
Identity | Size Confirmed Against an RNA Ladder |
On the pathway to GMP manufacturing in support of clinical trials, multiple technology transfers may correlate to an increase in complexity and risk...
March 22, 2022 8 am PT, 11 am ET, 16:00 CET Messenger RNA (mRNA) and self-amplifying RNA (saRNA) unravel new possibilities for the treatment and...
Aldevron, a leading research to GMP biomanufacturer of plasmid DNA, mRNA, and proteins, and Ginkgo Bioworks, Inc. ("Ginkgo") today announced a...
mRNA’s rise amidst the COVID pandemic The introduction of mRNA vaccines by Pfizer and Moderna for COVID-19 took much of the world by surprise. But...